Short Communication The HRAS1 Variable Number of Tandem Repeats and Risk of Breast Cancer

Rare alleles at the HRAS1 variable number of tandem repeats (VNTRs) locus have been implicated in breast cancer risk. We assessed the association of rare HRAS1 alleles and breast cancer in a case-control study nested within the Nurses’ Health Study cohort. Using PCRbased methods, 717 incident breast cancer cases and 798 controls were genotyped for the HRAS1 VNTRs. The prevalence of the rare alleles in breast cancer cases was not different compared with controls (10.7 versus 12.0%, respectively; P 0.45, two-sided Cochran-MantelHaenzel 2 test). There was no evidence that women heterozygous (multivariate odds ratio, 0.97; 95% confidence interval, 0.73–1.27) or homozygous (multivariate odds ratio, 0.83; 95% confidence interval, 0.32–2.14) for rare alleles were at an increased risk of breast cancer or that a positive gene-dose effect existed. The results did not vary by menopausal status. Although as a group the rare alleles were not associated with breast cancer, one class of rare alleles between the common alleles of a3 and a4 was associated with a significantly increased risk. These results suggest that there is no overall association between rare alleles of the HRAS1 VNTR and breast cancer.

[1]  J. Armour,et al.  Evolution and population genetics of the H-ras minisatellite and cancer predisposition. , 2003, Human molecular genetics.

[2]  W. Willett,et al.  The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. , 2002, Cancer research.

[3]  R. Nelson,et al.  The HRAS1 minisatellite locus and risk of ovarian cancer. , 2000, Cancer research.

[4]  G. Giles,et al.  HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. , 1999, Journal of the National Cancer Institute.

[5]  R. Rosell,et al.  Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  T. Krontiris,et al.  Distinct mutation patterns of breast cancer-associated alleles of the HRAS1 minisatellite locus. , 1999, Human molecular genetics.

[7]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[8]  J. Godbold,et al.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. , 1997, Environmental health perspectives.

[9]  A. Jeffreys,et al.  Big, bad minisatellites , 1997, Nature Genetics.

[10]  B. Hulka,et al.  Internal sequence variations in the Ha-ras variable number tandem repeat rare and common alleles identified by minisatellite variant repeat polymerase chain reaction. , 1996, Cancer research.

[11]  N. Risch,et al.  An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. , 1993, The New England journal of medicine.

[12]  B. Hulka,et al.  HRAS protooncogene polymorphism and breast cancer. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  W. Trepicchio,et al.  Members of the rel/NF-kappa B family of transcriptional regulatory proteins bind the HRAS1 minisatellite DNA sequence. , 1992, Nucleic acids research.

[14]  T. Krontiris,et al.  Minisatellite allele diversification: the origin of rare alleles at the HRAS1 locus. , 1990, American journal of human genetics.

[15]  E. Liu,et al.  Ha-ras rare alleles in breast cancer susceptibility , 2004, Breast Cancer Research and Treatment.

[16]  D. Parkinson,et al.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients , 1985, Nature.